Glucocorticoid/NN
receptor/NN
in/IN
patients/NNS
with/IN
lupus/NN
nephritis/NN
:/:
relationship/NN
between/IN
receptor/NN
levels/NNS
in/IN
mononuclear/JJ
leukocytes/NNS
and/CC
effect/NN
of/IN
glucocorticoid/NN
therapy/NN
./.

We/PRP
investigated/VBD
the/DT
clinical/JJ
significance/NN
of/IN
glucocorticoid/NN
receptor/NN
determination/NN
in/IN
20/CD
patients/NNS
with/IN
systemic/JJ
lupus/NN
erythematosus/NN
(/(
SLE/NN
)/)
who/WP
afterwards/RB
developed/VBD
nephrotic/JJ
syndrome/NN
./.
=====
Glucocorticoid/NN
receptor/NN
concentrations/NNS
in/IN
mononuclear/JJ
leukocytes/NNS
(/(
MNL/NNS
)/)
in/IN
these/DT
patients/NNS
were/VBD
comparable/JJ
with/IN
those/DT
in/IN
both/CC
other/JJ
patients/NNS
with/IN
SLE/NN
and/CC
healthy/JJ
persons/NNS
./.
=====
Improvement/NN
in/IN
urinary/JJ
protein/NN
excretion/NN
and/CC
in/IN
disease/NN
activity/NN
,/,
which/WDT
was/VBD
scored/VBN
according/VBG
to/TO
the/DT
SLE/NNP
Disease/NNP
Activity/NNP
Index/NNP
system/NN
of/IN
the/DT
University/NNP
of/IN
Toronto/NNP
,/,
closely/RB
related/JJ
to/TO
the/DT
glucocorticoid/NN
receptor/NN
concentrations/NNS
in/IN
MNL/NN
isolated/VBN
from/IN
the/DT
corresponding/JJ
patients/NNS
./.
=====
In/IN
summary/NN
,/,
glucocorticoid/NN
receptor/NN
determination/NN
in/IN
patients/NNS
with/IN
lupus/NN
nephritis/NN
may/MD
be/VB
a/DT
predictive/JJ
clue/NN
for/IN
assessing/VBG
responsiveness/NN
to/TO
glucocorticoid/NN
therapy/NN
./.